N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Sponsor: Fred Hutchinson Cancer Center • ClinicalTrials.gov ID: NCT07141407

Registry updated: 2026-08-25
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This clinical trial studies whether telephone-based coaching sessions, Talking About Cancer (TAC), work to improve engagement in advance care planning (ACP) in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and their support person. Participation in ACP, which includes having end of life (EOL) care conversations and completing advance directives (e.g., living will, health care proxy, do not resuscitate order), improves quality EOL care. Despite this, less than half of patients with advanced cancer have EOL care conversations or complete advance directives. TAC coaching sessions are delivered by a social worker over the phone. They are designed to help patients and their support person communicate about ACP, manage the distress these conversations can cause, and participate in the process of ACP with a clear action plan of having goals-of-care conversations and completing advance directives. This may be an effective way to improve ACP participation in advanced cancer patients and their support person.

Interventions

  • Supportive Care (Other)
    Attend TAC telephone-based coaching sessions
  • Telephone-Based Intervention (Behavioral)
    Attend TAC telephone-based coaching sessions
  • Survey Administration (Other)
    Ancillary studies
  • Educational Intervention (Other)
    Receive an ACP brochure/handout

Eligibility criteria

Inclusion Criteria: * PATIENT: Current diagnosis of stage III or IV cancer * PATIENT: Able to provide informed consent * PATIENT: Fluent in English or Spanish * PATIENT: Have access to a telephone, computer, or mobile device * CAREGIVER (SUPPORT PERSON): Person patient indicates provides support * CAREGIVER (SUPPORT PERSON): English or Spanish speaking * CAREGIVER (SUPPORT PERSON): 18 years of age or older * CAREGIVER (SUPPORT PERSON): Able to provide informed consent Exclusion Criteria: * PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer) * PATIENT: Receiving hospice at the time of enrollment * PATIENT: Younger than age 18

Conditions

Advanced Malignant Solid Neoplasm Hematopoietic and Lymphatic System Neoplasm

Locations

  • Providence Regional Cancer Partnership — Everett, Washington, United States
  • Skagit Regional Health Cancer Care Center — Mount Vernon, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record